UM  > 中華醫藥研究院
Zebrafish as a new model for drug metabolism and high content screen of natural product
Lee, SMY1,2; Hoi, PM1,2; Yan, R1,2; Wang, YQ3; Han, YF4; Chu, IK5
Source PublicationPLANTA MEDICA

In recent years, zebrafish has become an increasingly used model in the field of drug screening. Our recent study addressed drug absorption and metabolism in zebrafish embryos and larvae. LCMS/MS was used to identify and profile the metabolites of icaritin glycoside derivatives, which are prenylated flavonoid compounds, in zebrafish larvae. The result showed that the metabolic pathway involving the enzymatic removal of the sugar moiety of these compounds to produce the free aglycone, which is subsequently conjugated by sulfation, glucuronidation, or methylation or in different combinations [1]. Moreover, transcriptomic profiling identified 51 unique mRNA transcripts that belong to several key enzymes involved in phase I drug metabolism and phase II drug metabolism enzymes [1]. The result supports the functional similarity of drug metabolism systems in zebrafish and mammals [1]. Furthermore, a structure-activity relationship analysis of antiangiogenesis activities of a series of methoxyflavone derivatives using zebrafish assay indicated that sinensetin with a methoxylated group at the C3 position offers a stronger antiangiogenesis activity, whereas the absence of a methoxylated group at the C8 position offers lower lethal toxicity in addition to enhancing the antiangiogenesis activity [2]. In addition, zebrafish behavioural assays have shown promise for the discovery of neuroactive compounds such as quercetin, indoles containing analogues and tetramethylpyrazine analogues [3 – 4]. Taken together, our findings demonstrated that zebrafish has proven to be a suitable model for in vivo high content drug screening, and for simultaneous determination of multiple parameters, including behaviour, selectivity, and toxicity. Zebrafish screen of natural products has the potential to identify reproducible, higher potency and lower toxic agents for healthcare in the future.

KeywordNeurodegeneration Chinese Medicine Zebrafish Drug Metabolism Vascular Disease
Indexed BySCI
WOS Research AreaPlant Sciences ; Pharmacology & Pharmacy ; Integrative & Complementary Medicine
WOS SubjectPlant Sciences ; Chemistry, Medicinal ; Integrative & Complementary Medicine ; Pharmacology & Pharmacy
WOS IDWOS:000345550400043
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Affiliation1.Univ Macau, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China
2.Univ Macau, Inst Chinese Med Sci, Taipa, Peoples R China
3.Jinan Univ, Coll Pharm, Inst New Drug Res, Guangzhou, Guangdong, Peoples R China
4.Hong Kong Polytech Univ, Inst Modern Med, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China
5.Univ Hong Kong, Dept Chem, Pokfulam, Hong Kong, Peoples R China
First Author AffilicationUniversity of Macau
Recommended Citation
GB/T 7714
Lee, SMY,Hoi, PM,Yan, R,et al. Zebrafish as a new model for drug metabolism and high content screen of natural product[J]. PLANTA MEDICA,2014,80(16).
APA Lee, SMY,Hoi, PM,Yan, R,Wang, YQ,Han, YF,&Chu, IK.(2014).Zebrafish as a new model for drug metabolism and high content screen of natural product.PLANTA MEDICA,80(16).
MLA Lee, SMY,et al."Zebrafish as a new model for drug metabolism and high content screen of natural product".PLANTA MEDICA 80.16(2014).
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Lee, SMY]'s Articles
[Hoi, PM]'s Articles
[Yan, R]'s Articles
Baidu academic
Similar articles in Baidu academic
[Lee, SMY]'s Articles
[Hoi, PM]'s Articles
[Yan, R]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Lee, SMY]'s Articles
[Hoi, PM]'s Articles
[Yan, R]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.